Browse > Article

A Study of Central and Peripheral type of Eye Movement Impairment - Focused on 3 Cases Treated with Oriental Medical Treatment  

Park, Joon-Young (Dept. of Cardiovascular and Neurologic Disease, Oriental Medicine Hospital, Kyung-Hee University)
Kim, Young-Seok (Dept. of Cardiovascular and Neurologic Disease, Oriental Medicine Hospital, Kyung-Hee University)
Cho, Ki-Ho (Dept. of Cardiovascular and Neurologic Disease, Oriental Medicine Hospital, Kyung-Hee University)
Mun, Sang-Kwan (Dept. of Cardiovascular and Neurologic Disease, Oriental Medicine Hospital, Kyung-Hee University)
Jung, Woo-Sang (Dept. of Cardiovascular and Neurologic Disease, Oriental Medicine Hospital, Kyung-Hee University)
Publication Information
The Journal of Internal Korean Medicine / v.33, no.4, 2012 , pp. 599-608 More about this Journal
Abstract
Objectives : To report three cases of eye movement impairment: internuclear ophthalmoplegia (INO) due to pontine infarction, traumatic abducens nerve palsy, and abducens nerve involvement in Miller-Fisher syndrome. Cases Summary : There were three cases. First, a 64-year-old woman, who was given a diagnosis of INO due to pontine infarction, had left gaze palsy of her right eye while the convergence was intact. Second, a 34-year-old man had abduction impairment of his right eye after a traffic accident. Third, a 66-year-old man, who was diagnosed with Miller-Fisher syndrome, had left gaze palsy of his left eye. Their symptoms improved substantially and their anxieties were relieved after treatment with herbal medicine and acupuncture. Conclusions : There has been no certain cure for eye movement impairment yet. In this report, we present three successful cases of patients with eye movement impairment and show that Korean medical treatment could be a solution for this incurable disease.
Keywords
eye movement impairment; internuclear ophthalmoplegia (INO); medial longitudinal fasciculus (MLF) syndrome; abducens nerve palsy; Miller-Fisher syndrome;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Goodall JA, Kosmidis JC, Geddes AM. Effect of corticosteroids on course of Guillain-Barre syndrome. Lancet 1974;303(7857):524-6.   DOI   ScienceOn
2 Zifko U, Drlicek M, Senantka G, Grisold W. High dose immunoglobulin therapy is effective in the Miller Fisher syndrome. J Neurol 1994; 241(3):178-9.
3 Yeh JH, Chen WH, Chen JR, Chiu HC. Miller Fisher syndrome with central involvement: successful treatment with plasmapheresis. Ther Apher 1999;3(1):69-71.   DOI   ScienceOn
4 조기호. 한방처방의 동서의학적 해석방법론. 서울: 고려의학; 1999, p. 447.
5 이광우, 강동화, 강사윤, 강지훈, 구자성, 권순억, 등. 신경과학. 서울: 이퍼블릭; 2009, p. 69-75.
6 배춘상, 백선용, 조희중, 천명훈, 차중익. 신경해부학. 서울: 고문사; 1995, p. 197.
7 신정애, 손동혁, 이태호, 변덕시, 윤희식, 장인수. 제 3,4,6 뇌신경 마비로 인한 안구운동장애 환자 한방치험 3례. 대한한방내과학회지. 2003;24(3): 626-34.
8 북경중의학원. 제병원후론교석. 북경: 인민위생출판사; 1983, p. 782.
9 허준. 동의보감. 서울: 남산당; 2004, p. 219-26.
10 김창환, 김용석. 외전신경마비 사시환자의 한방치험 1례. 대한한의학회지 1997;18(1):82-6.
11 Kim JS. Internuclear ophthalmoplegia as an isolated or predominant symptom of brainstem infarction. Neurology 2004;62(9):1491-6.   DOI   ScienceOn
12 Zee DS, Hain TC, Carl JR. Abduction nystagmus in internuclear ophthalmoplegia. Ann Neurol 1987;21(4):383-8.   DOI   ScienceOn
13 Eggenberger E, Golnik K, Lee A, Santos R, Suntay A, Satana B, et al. Prognosis of ischemic internuclear ophthalmoplegia. Ophthalmology 2002; 109(9):1676-8.   DOI   ScienceOn
14 김성식, 진경현, 김상민. 제3,4,6 뇌신경마비의 신경안과적 관찰. 대한안과학회지 1991;32(4): 283-8.
15 Rush JA, Young BR. Paralysis of cranial nerves III, IV, and VI. Arch opthalmol 1981; 9(9):76-9.
16 민병무, 김남중. 동안신경마비로 인한 외사시의 교정술. 대한안과학회지 1995;36(8):136-41.
17 Berlit P, Rakicky J. Miller Fisher syndrome. Review of the literature. J Clin Neuroophthalmol 1992;12:57-63.
18 LI H, Yuan J. Miller Fisher syndrome: toward a more comprehensive understanding. Chin Med J 2001;104:235-9.
19 Lo YL. Clinical and immunological spectrum of the Miller Fisher syndrome. Muscle Nerve 2007;36:615-27.   DOI   ScienceOn
20 Roberts M, Willison H, Vincent A, Newsom-Davis J. Serum factor in Miller Fisher varient of Guillain-Barre syndrome and neurotransmitter release. Lancet 1994;343(8895):454-5.   DOI   ScienceOn